HDII OTC
Hypertension Diagnostics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +9900.0%
3Y: -96.4%
5Y: -99.4%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$122K
-1008.1% ▼
Net Income
-$93K
-747.7% ▼
EPS (Diluted)
$-0.00
-300.0% ▼
EBITDA
$135K
-747.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $4M | $4M | $0 | $0 | $0 |
| YoY Growth | +3.1% | +3.1% | -100.0% | +0.0% | +0.0% |
| Cost of Revenue | $3M | $3M | $0 | $0 | $0 |
| Gross Profit | $752K | $954K | $0 | $0 | $0 |
| Gross Margin | 20.5% | 25.2% | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $966K | $918K | $420K | $11K | $122K |
| Operating Expenses | $1M | $1M | $420K | $11K | $122K |
| Operating Income | -$403K | -$161K | -$420K | -$11K | -$122K |
| Operating Margin | -11.0% | -4.2% | — | — | — |
| Interest Expense | $159K | $162K | $0 | $0 | $0 |
| Income Before Tax | -$369K | -$125K | $3M | -$11K | -$93K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$369K | -$125K | $3M | -$11K | -$93K |
| Net Margin | -10.0% | -3.3% | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.00 | $0.02 | $-0.00 | $-0.00 |
| EBITDA | -$179K | $72K | $4M | $226K | $135K |
| Shares Outstanding | 93M | 137M | 137M | 149M | 213M |